Transferrin saturation versus reticulocyte hemoglobin content for iron deficiency in Japanese hemodialysis patients.

@article{Kaneko2003TransferrinSV,
  title={Transferrin saturation versus reticulocyte hemoglobin content for iron deficiency in Japanese hemodialysis patients.},
  author={Yoshikatsu Kaneko and Shigeru Miyazaki and Yoshihei Hirasawa and Fumitake Gejyo and Masashi Suzuki},
  journal={Kidney international},
  year={2003},
  volume={63 3},
  pages={
          1086-93
        }
}
BACKGROUND Iron deficiency is a frequent cause of recombinant human erythropoietin (rhEPO)-resistant anemia in hemodialysis patients. Both reticulocyte hemoglobin content (CHr) and transferrin saturation (TSAT) have been proposed as markers of iron deficiency, but it is unclear which parameter is superior. METHODS To compare the efficacy of CHr and TSAT as an indicator for treatment of iron deficiency, we conducted a single-center, open-label, prospective, randomized, controlled trial at the… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 22 CITATIONS

Similar Papers

Loading similar papers…